At this stop on Pharma's Almanac's Road to 50 States trans-American road trip, Stephanie Reed, Director of Translational Product Development at the Secant Group, talks to Nigel about the company's focus on small molecule portfolios and how Secant's new Hydralese platform provides long-acting drug delivery of small molecules and biologics.
